The 2023 discoveries that made us rethink the story of human evolution
Historic FDA approval of the first CRISPR-Cas9 drug for Sickle Cell Disease based on discoveries from Jennifer Doudna & Emmanuelle Charpentier, CRISPR Therapeutics & Vertex Pharmaceuticals.
Stonehenge study upends a 100-year-old theory and suggests further discoveries to come